Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Net Margin (2023 - 2025)

CervoMed (CRVO) has disclosed Net Margin for 8 consecutive years, with 92718.1% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 9240780.0% to 92718.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 672.86% through Dec 2025, down 50554.0% year-over-year, with the annual reading at 672.86% for FY2025, 50558.0% down from the prior year.
  • Net Margin hit 92718.1% in Q4 2025 for CervoMed, down from 2394.96% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 70.44% in Q2 2024 to a low of 92718.1% in Q4 2025.
  • Historically, Net Margin has averaged 8074.42% across 3 years, with a median of 208.61% in 2023.
  • Biggest five-year swings in Net Margin: increased 11bps in 2024 and later crashed -9240780bps in 2025.
  • Year by year, Net Margin stood at 94.83% in 2023, then crashed by -227bps to 310.3% in 2024, then crashed by -29780bps to 92718.1% in 2025.
  • Business Quant data shows Net Margin for CRVO at 92718.1% in Q4 2025, 2394.96% in Q3 2025, and 355.47% in Q2 2025.